Live Quote · NASDAQARQTHealthcare· Biotechnology

Arcutis Biotherapeutics, Inc.

$26.36▼ 2.98%($-0.81)
MKT CAP $3.33BNEXT EARNINGS Feb 24, 2027
50%
Bullish
TickerSpark Score
72/100
▌ Solid
43
Valuation
80
Profitability
100
Growth
76
Health
60
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ARQT research report →

Analyst Price Target
$41.80+58.6% vs. today

Range $38 – $48

Analyst RatingBuy
10 Buy2 Hold0 Sell

Price Chart

-3.55% · this period
$34.05$26.77$19.50Nov 20May 26Nov 20
52-Week Range46% of range
Low
$19.30
Current
$26.36
High
$34.80